Skip to content

Medical emergency? What to do

Misuse led to drug-resistant flu strains -experts

3-RXPublished February 3, 20062 min read

Key points

  • Misuse of two anti-viral drugs in China, Russia and other countries likely led to the development of resistant influenza strains against which the drugs are now nearly useless, health experts said on Thursday.
  • Centers for Disease Control and Prevention said 120 samples of the most prevalent flu strain in the country this season showed it was resistant to amantadine and rimantadine in 91 percent of cases.
  • "The rate of adamantane resistance began to increase in Asia in the 1997-1998 influenza season and increased markedly in China to 57 percent in 2002-2003 and 73 percent in 2003-2004," they said.
  • Viruses and bacteria can adapt and become resistant to drugs used to treat them when the drugs are overused or not taken appropriately.

Misuse of two anti-viral drugs in China, Russia and other countries likely led to the development of resistant influenza strains against which the drugs are now nearly useless, health experts said on Thursday.

The medicines involved are amantadine and rimantadine, used to treat common seasonal influenza but not intended to combat the avian flu strain that has killed at least 85 people since 2003 and which experts fear could mutate and cause a global pandemic.

Last month the U.S. Centers for Disease Control and Prevention said 120 samples of the most prevalent flu strain in the country this season showed it was resistant to amantadine and rimantadine in 91 percent of cases. The resistance level was only 11 percent the previous flu season.

David Weinstock and Gianna Zuccotti, two doctors at Memorial Sloan-Kettering Cancer Center, New York, said that development was "a clarion call for action from the medical community."

"The rate of adamantane resistance began to increase in Asia in the 1997-1998 influenza season and increased markedly in China to 57 percent in 2002-2003 and 73 percent in 2003-2004," they said. Adamantane describes the class of drugs to which amantadine and rimantadine belong.

"Misuse of adamantanes most likely contributed to this rapid increase in resistance," they added. "In China, Russia and some other countries, amantadine and rimantadine are both available without a prescription and are included in over-the-counter 'antiflu' and 'cold' preparations at a range of doses."

Viruses and bacteria can adapt and become resistant to drugs used to treat them when the drugs are overused or not taken appropriately.

Weinstock and Zuccotti urged doctors and health care professionals to educate patients and communities, organize an international response and work against the release of over-the-counter antiviral drugs, either directly by major drug companies or through licensing agreements with generic manufacturers.

They made the comments in an editorial accompanying a report from the CDC, both of which are to be published in the Journal of the American Medical Association.

In the CDC study, researchers said the resistance is widespread and affects flu strains in all regions of the United States and other areas of North America as well.

The CDC last month urged doctors not to use the two drugs to prevent flu or to treat patients suspected of having it because the drugs are no longer effective. Doctors instead should prescribe either of two newer medicines, Tamiflu or Relenza, which still fight the strain, the agency said. Tamiflu is made by Roche Holding AG and Relenza by GlaxoSmithKline Plc.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.